Meta-analysis of 7 non-randomised real-world studies (7112 infants): maternal RSVpreF vaccination ≥14 days before delivery was associated with 82% effectiveness against RSV LRTI hospitalisation to age 3 months and 78% to 6 months.
Meta-analysisn = 7,112
Batool et al. RSV Bivalent Prefusion F Protein Vaccine in Pregnancy and Protection Against RSV-Associated Illness in Infants: A Systematic Review and Meta-Analysis